DARWIN
BRANDS & COMPANIES
BRANDS
NOVODAILY
GENOPEDIA
Browse through our online encyclopedia for genetics and see what our Deep Genome AI engine has gathered from millions of scientific publications as a basis of automated genome analysis.
GENIUS
Genius is an innovative start-up of Darwin AG and, together with biotechnology company Novogenia, offers personalized health solutions for pharmacies – ranging from genetic diagnostics and individually tailored micronutrients to customized cosmetics. Using cutting-edge laboratory technology and scientifically validated analyses, we enable pharmacies to provide more precise and effective consultations, reinforcing their role as centers of modern preventive healthcare.
Pharmacies benefit from over 15 years of global research in the field of human genetics.
COMPANIES
Novogenia GmbH
Salzburg, Austria
100% of Novogenia’s shares are owned by DARWIN AG.
Founded in 2009, Novogenia is one of the leading European companies in nutri genetics and preventive genetic testing. At its headquarters in Salzburg, Austria, Novogenia has built a state of the art medical genetic testing laboratory and has developed novel technologies for the personalization of nutritional supplements and cosmetics based on lab analysis data. The company currently employs a staff of 250 employees. Its 4000m² facility currently houses the laboratory, the supplement and cosmetics manufacture and administration. In 2023-2024, Novogenia will complete its new facility at the same location and increase its production space 3-fold and the Laboratory space 5 fold, with the aim of being able to generate a total of €500 Million of annual revenue at this site.
Novogenia is a service provider for OEM partnerships and develops and distributes its products and services through various B2B channels.
Novogenia Marketing GmbH
Salzburg, Austria
100% of Novogenia Marketing GmbH shares are owned by DARWIN AG.
Novogenia Marketing GmbH is focused at marketing the products and services of Novogenia to the public. Under the consumer brand NovoDaily, various laboratory analyses (samples collected at home) are offered through omnichannel marketing, leading to a personalized lab data driven nutrient recipe, users can purchase under a subscription plan.
HLN Genetik GmbH
Vienna, Austria
DARWIN acquired the controlling majority of HLN Genetik in 2022
Positioned on the highest end of medical genetics, the analysis of embryonic DNA before implantation to boost In Vitro Fertilization success, HLN Genetik is led by Austria’s leading experts in the field of Medical genetics. The laboratory holds the exclusive license for preimplantation genetic testing in Austria and an extensive license for medical diagnostic testing for all genetic diseases known to science. DARWIN acquired the controlling majority of HLN Genetik in 2022 and aims to expand its medical diagnostic portfolio throughout Austria and beyond.
Mendelio
Romania
Mendelio is DARWINs in house software development team. Skilled specialists develop software and artificial intelligence engines for all of DARWINS companies and partners. All Software developed by DARWIN is in house and the IP of DARWIN.
NovoMedic GmbH
Salzburg, Austria
NovoMedic is a DARWIN in-house Startup specializing in personalized supplement solutions for medical professionals. With a wide portfolio of Novogenia blood and DNA tests, clinicians can offer nutrition relevant testing to their patients. Together with the lab results, clinicians receive a recommended nutrient recipe, that the clinician can adapt with their expertise. The patient receives a subscription based steady supply of personalized supplements.
INVESTMENTS
LykonDX GmbH
Berlin, Germany
lykon.com
Positioned on the highest end of medical genetics, the analysis of embryonic DNA before implantation to boost In Vitro Fertilization success, HLN Genetik is led by Austria’s leading experts in the field of Medical genetics. The laboratory holds the exclusive license for preimplantation genetic testing in Austria and an extensive license for medical diagnostic testing for all genetic diseases known to science. DARWIN acquired the controlling majority of HLN Genetik in 2022 and aims to expand its medical diagnostic portfolio throughout Austria and beyond.
SpotKits Inc.
USA
GenomeLink Inc.
USA
Nephrogen Inc.
USA
